Lumpectomy News and Research

RSS

Study reveals how different breast cancer treatments impact employment experiences of women

A new study reveals that patients with breast cancer who received more aggressive treatments were more likely to experience disruptions in employment. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may be helpful for patients who are comparing their options for breast cancer treatment.

9 Oct 2017

$Hypofractionated breast radiation therapy safe and effective in women under 50, study finds$

Hypofractionated breast radiation therapy safe and effective in women under 50, study finds

A higher-dose, shorter form of radiation is safe, effective, and no more damaging to the breast tissue or skin of breast cancer patients under age 50 than it is in older patients.

25 Sep 2017

Study explores long-term consequences of breast surgery on woman's sensuality, sexual function

Does the type of surgery used to treat breast cancer impact a woman's sensuality and sexual function in survivorship? New research from Women & Infants Hospital analyzed the association of surgical modality with sexual function and found that breast-specific sensuality and appearance satisfaction are better with lumpectomy and may correlate with improved sexual function post-operatively.

26 Jul 2017

Adding a second HER2-targeted treatment may improve outcomes for some women with breast cancer

A phase III clinical trial of 4,805 women with HER2-positive breast cancer suggests adding a second HER2 targeted medicine, pertuzumab (Perjeta), to standard of care trastuzumab (Herceptin) after surgery may help, although the benefit is modest.

6 Jun 2017

CLI could be promising technique for assessing tumor margins during breast-conserving surgery

Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries.

1 Jun 2017

Researchers develop new imaging technique to ensure complete removal of tumor during surgery

Of the quarter-million women diagnosed with breast cancer every year in the United States, about 180,000 undergo surgery to remove the cancerous tissue while preserving as much healthy breast tissue as possible.

18 May 2017

Study finds shorter course of radiation therapy given after mastectomy to be safe and effective

A shorter course of radiation therapy given to breast cancer patients following mastectomy is safe and effective and cuts treatment time in half. That is according to data from a phase II clinical trial conducted by Rutgers Cancer Institute of New Jersey investigators and other colleagues who examined a hypofractionated regimen given over three weeks versus the traditional six week course of treatment.

2 May 2017

Different therapies for early-stage breast cancer show wide variations in cost-effectiveness

A new study published today in the Journal of the National Cancer Institute indicates that different therapies for early-stage breast cancer have very different relative values.

10 Apr 2017

Shorter radiation treatment for breast cancer patients could reduce health care spending

More than half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study led by Duke Cancer Institute researchers.

15 Mar 2017

Study explores links between genetic susceptibility and heterogeneous phenotypes of lymphedema

Each year, about 1.38 million women worldwide are diagnosed with breast cancer. Advances in diagnosis and treatment have facilitated a 90-percent, five-year survival rate, among those treated.

9 Feb 2017

Study finds under and misuse of adjuvant endocrine therapy for breast cancer patients

A nationwide cancer registry of almost one million patients treated for hormone-sensitive breast cancer shows that one out of six women who should have received post-surgical treatment known as adjuvant endocrine therapy (AET) did not get this recommended component of care.

3 Feb 2017

Mayo Clinic to test vaccine for providing lifelong immunity against precancerous breast lesions

Only about 35 percent of precancerous breast lesions morph into cancer if untreated, but physicians cannot identify which lesions are potentially dangerous.

2 Feb 2017

Study: Half of women treated for early stage breast cancer report severe side effects

Nearly half of women treated for early stage breast cancer reported at least one side effect from their treatment that was severe or very severe, a new study finds.

24 Jan 2017

Study examines health care costs linked to lumpectomy patients requiring reoperations

The number of breast cancer patients that have to be reoperated on in Canada is too high and impacts patient wellbeing and health care costs, according to UBC research.

16 Dec 2016

Study identifies recurrent genomic alterations in subset of breast cancer

A genomic analysis study by Rutgers Cancer Institute of New Jersey investigators and other colleagues has identified recurrent genomic alterations in a subset of breast cancer that are typically associated with a form of thyroid cancer and an intestinal birth defect known as Hirschsprung disease.

9 Dec 2016

How could emerging technologies impact cancer care?

The major innovations in cancer diagnosis, therapy/palliative care and surgical intervention are too numerous to list here. But enormous strides have taken place in stem cell therapy, monoclonal antibody therapy and genetic screening.

17 Oct 2016

Radiation boost provides added benefit to DCIS patients following breast-conserving surgery and WBRT

A supplemental "boost" of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with Ductal Carcinoma In Situ (DCIS) who receive whole breast radiation therapy radiation (WBRT) following lumpectomy, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

27 Sep 2016

Hidden Scar approach minimizes visible breast cancer scars

PinnacleHealth Breast Care Surgeons Lisa Torp, Brynn Wolff and Katherine Barton are the first in Pennsylvania to be recognized for Excellence in Hidden Scar™ Breast Cancer Surgery.

21 Sep 2016

Breast cancer patients in the U.S. now have new surgical option that offers flexible alternative for cancer detection

Breast cancer patients in the U.S. will have a new surgical option that eliminates exposure to radioactive materials and offers a less invasive, more flexible alternative for cancer detection. Receiving FDA approval in April and a distribution deal this month, the new device will be used to locate early stage tumors that cannot yet be felt.

24 Aug 2016

Study reveals needle biopsy hormone receptor testing for DCIS wastes millions

For patients with the most common type of noninvasive breast cancer, routine testing for estrogen and progesterone receptors in tissue taken at the first "needle" biopsy is both unnecessary and wasteful, according to results of a study led by Johns Hopkins pathologists.

9 Aug 2016